Cafepharma Today

June 27 2025 - ACIP skips votes on COVID and Moderna’s mRESVIA but scrutinzes mRNA vaccine safety
ACIP skips votes on COVID and Moderna’s mRESVIA but scrutinzes mRNA vaccine safety
VC legal dispute threatens biotech startups
Multiple sclerosis market expected to reach $25.9bn across the 7MM by 2034
Novo Nordisk Foundation gives $75m for R&D 'challenges'
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BGI-Shenzhen Extends Tender Offer for Complete Genomics, Inc.
Yahoo/PR Newswire
Saturday, January 12, 2013 - 10:38am
tags:
BGI-Shenzhen, Complete Genomics, M&A
1 Problem This Pharma Doesn’t Want to Talk About
Motley Fool
Saturday, January 12, 2013 - 10:36am
tags:
Copaxone, Teva Pharmaceuticals, multiple sclerosis, MS, patents
1 Problem This Pharma Doesn’t Want to Talk About
Motley Fool
Saturday, January 12, 2013 - 10:36am
tags:
Copaxone, Teva Pharmaceuticals, multiple sclerosis, MS
Will Sarepta Be Bought Out in 2013?
Motley Fool
Saturday, January 12, 2013 - 10:34am
tags:
Sarepta Therapeutics
Alexion Pharmaceuticals Inc.: Today's Featured Drugs Laggard
The Street
Saturday, January 12, 2013 - 10:34am
tags:
Alexion
Banking on Biotech
CNBC
Saturday, January 12, 2013 - 10:33am
tags:
Regeneron, Biogen Idec, Acorda Therapeutics, Sanofi, Celgene, Alexion, Biomarin, NPS Pharmaceuticals, Cerner, EXACT Sciences, Pfizer, Bristol-Myers Squibb, Eli Lilly
Sarepta May Seek Partnership Advice for Experimental Drug
Bloomberg
Saturday, January 12, 2013 - 10:29am
tags:
Sarepta Therapeutics, eteplirsen, Duchenne Muscular Dystrophy
Humira Will Help AbbVie Prevail, A Great Buy With Low Valuation
Seeking Alpha
Friday, January 11, 2013 - 12:43pm
tags:
Humira, AbbVie, Abbott Laboratories
Celsion's Phase III Blockbuster Data Revealed And It's Been Right Underneath Your Nose
Seeking Alpha
Friday, January 11, 2013 - 12:16pm
tags:
Celsion, ThermoDox
Will Qsymia's Stellar Sales Growth Continue?
Motley Fool
Friday, January 11, 2013 - 12:15pm
tags:
Vivus, Qsymia, obesity
10 Biotech Stocks With A History Of Beating Earning Expectations
TheStreet.com
Friday, January 11, 2013 - 12:14pm
tags:
Alexion, Regeneron, Optimer, Targacept, Osiris, Array Biopharma, YM BioSciences, Questcor Pharmaceuticals, Charles River Laboratories, Illumina
Sarepta May Seek Partnership Advice for Experimental Drug
Bloomberg
Friday, January 11, 2013 - 12:12pm
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Dendreon Rises on Optimism Over Cancer Drug Provenge
Bloomberg
Friday, January 11, 2013 - 12:05pm
tags:
Dendreon, prostate cancer, Provenge
Good Chance For PharmAthene To Jump On Lucrative SIGA Litigation
Seeking Alpha
Friday, January 11, 2013 - 12:05pm
tags:
PharmAthene, SIGA technologies
Novartis says Afinitor reduces tumors in rare genetic disease
Reuters
Friday, January 11, 2013 - 11:57am
tags:
Afinitor, Novartis, TSC
Glaxo Future Hangs in Balance on 2013 U.S. Drug Approvals
Bloomberg
Friday, January 11, 2013 - 11:56am
tags:
GSK, drug approvals, albiglutide, relvar, Dolutegravir
J&J Failed to Warn of Vaginal Mesh Risks, Lawyer Says
Bloomberg
Friday, January 11, 2013 - 11:40am
tags:
JNJ, vaginal mesh
JPMorgan Healthcare Conference Highlights: Questcor Pharmaceuticals
Motley Fool
Friday, January 11, 2013 - 11:39am
tags:
JPMHC 2013, Questcor Pharmaceuticals
FDA Panel Backs Novel Diabetes Pill From J&J
Motley Fool
Friday, January 11, 2013 - 11:38am
tags:
FDA, advisory panels, JNJ, diabetes, canagliflozin
Merck steers doctors away from HDL cholesterol drug Tredaptive
Yahoo/Reuters
Friday, January 11, 2013 - 11:37am
tags:
Merck, Tredaptive

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The "Healthy Vaccinee" Effect
In the Pipeline
The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.